secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001625297-25-000046
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior added to Russell 2000 and 3000 indexes effective June 30, 2025
-----------------------------------------------------------------------

- Inclusion follows 2025 Russell indexes annual reconstitution; membership lasts one year.
- CEO notes 85% of 2024 net revenue was U.S.-generated, mainly from SUBLOCADE.
- About $10.6 trillion in assets benchmarked to U.S. Russell indexes (FTSE Russell data).
- Stock also automatically added to corresponding growth and value indexes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000046/0001625297-25-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000046/indv-20250630.htm
  HTML page:      https://secwatch.observer/filing/0001625297-25-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer